Literature DB >> 1659200

Vaginal cancer: the role of infectious and environmental factors.

M J Merino1.   

Abstract

Primary cancers of the vagina are rare. They comprise 1% to 2% of all gynecologic malignancies and occur predominantly in older women. The diagnosis of primary carcinoma of the vagina requires that the cervix and vulva be intact and that no clinical evidence of other primary tumors exist. Approximately 90% of all vaginal tumors are squamous cell in type on histologic examination. Adenocarcinoma, which is much less common (2% to 4%), is seen primarily in younger women with in utero exposure to diethylstilbestrol. In addition to exposure to diethylstilbestrol, other environmental factors have been associated with the development of vaginal tumors, including chronic irritation from pessaries, previous hysterectomy for benign disease, immunosuppression therapy, cervical irradiation, and endometriosis. Infectious causes seem to play an even more pernicious role in vaginal cancer. The two agents most often implicated are herpes simplex virus and human papillomavirus. These viruses appear to serve as cofactors in the inducement of various genital cancers, working together or with environmental agents such as diethylstilbestrol and host-related genetic abnormalities. The prognosis of vaginal cancer depends on the stage of the disease, with an overall 5-year survival rate of 80% to 90% for early stages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659200     DOI: 10.1016/s0002-9378(12)90738-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  Vaginal metastasis presenting as postmenopausal bleeding.

Authors:  Qiu Ju Ng; Rama Padma Namuduri; Kwai Lam Yam; Soo Kim Lim-Tan
Journal:  Singapore Med J       Date:  2015-08       Impact factor: 1.858

3.  Protein Expression Profiling and Virtual Drug Screening as an Approach for Individualized Therapy of Small Cell Vaginal Carcinoma.

Authors:  Mohamed E M Saeed; Hassan E Khalid; Sailesh K Thakur; Thomas Efferth
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

Review 4.  A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.

Authors:  Ralph P Insinga; Kai-Li Liaw; Lisa G Johnson; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

5.  Vaginal cells of smokers are more resistant to human papillomavirus infection than that of non-smokers.

Authors:  Afsoon Moktar; Srivani Ravoori; Manicka V Vadhanam; Jianmin Pan; Shesh N Rai; Alfred B Jenson; Lynn P Parker; Ramesh C Gupta
Journal:  Exp Mol Pathol       Date:  2012-11-05       Impact factor: 3.362

6.  Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine.

Authors:  Maria Lina Diaz
Journal:  Int J Womens Health       Date:  2010-08-09

7.  Positive sentinel lymph node in a patient with clinical stage I vaginal cancer.

Authors:  Lauren Montemorano; Monica Hagan Vetter; Michael Blumenfeld; David M O'Malley
Journal:  Gynecol Oncol Rep       Date:  2020-06-14

Review 8.  Current update on vaginal malignancies.

Authors:  Rachel Stein; Dhakshinamoorthy Ganeshan; Dheeraj Reddy Gopireddy; Ammar Chaudhry; Sindhu Kumar; Karthik Bande; Priya Bhosale; Chandana Lall
Journal:  Abdom Radiol (NY)       Date:  2021-08-02

9.  Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.

Authors:  Eliane Duarte-Franco; Eduardo L Franco
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

10.  Using a pessary during radiotherapy in reducible pelvic organ prolapse and vaginal cancer: a case report and review of the literature.

Authors:  Melis Gultekin; Caglayan Selenge Beduk Esen; Utku Akgor; Mehmet Coskun Salman; Murat Tuncel; Mustafa Ozmen; Ferah Yildiz
Journal:  J Contemp Brachytherapy       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.